Removed from 503B Compounding (2024) CJC-1295 (with or without DAC) Growth hormone release Ipamorelin Growth hormone release Thymosin Alpha-1 Immune support AOD-9604 Fat loss Note: BPC-157 and TB-500 were removed from 503B outsourcing facility compounding in 2024 but remain available through 503A compounding pharmacies via patient-specific prescriptions
Limitations and open questions On the other side, pricing surfaces mainly after intake, totals vary widely, and like every telehealth service in this space the program prescribes from a questionnaire without reading your underlying biology
Improvements in lipid profiles often accompany glucose benefits and contribute to overall cardiovascular risk reduction
Supports ATP production and balances oxidative stress*
Its primarily used to enhance sexual arousal and treat dysfunction
But it means its even more important to plan what happens after weight lossdietary change and physical activity remain essential. Ongoing research is exploring maintenance-phase strategies, lower dosing and alternative compounds that might preserve metabolic benefits while minimizing side effects
